Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0363220110490070656
Korean Journal of Dermatology
2011 Volume.49 No. 7 p.656 ~ p.659
Granuloma Annulare Induced by Adalimumab
Oh Young-Jae

Choi Won-Jun
Ko Joo-Yeon
Ro Young-Suck
Abstract
Adalimumab is the first fully humanized monoclonal anti-tumor necrosis factor alpha (TNF-¥á) antibody. This drug has been shown to be of benefit in patients with inflammatory diseases in which TNF-¥á is involved, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn¡¯s disease. As the use of adalimumab is becoming more widespread, cutaneous side effects are being increasingly reported. Various dermatologic adverse events have been reported in the literature, including injection site reactions, psoriasis-like eruption and pityriasis rosea. Herein, we describe a case of GA associated with adalimumab treatment for adult-onset Still¡¯s disease, which has not been reported in Korea.
KEYWORD
Adalimumab, Granuloma annulare, TNF-¥á inhibitor
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø